Sonia M. F. de Morais

Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations

Joyce A. Goldstein, Takashi Ishizaki, Kan Chiba et al. · Pharmacogenetics · 1997 · 352 citations

A New Genetic Defect in Human CYP2C19: Mutation of the Initiation Codon Is Responsible for Poor Metabolism of S-Mephenytoin

Ronald J. Ferguson, Sonia M. F. de Morais, Simone Benhamou et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 199 citations

Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome

Sonia M. F. de Morais, Jack Uetrecht, Peter G. Wells · Gastroenterology · 1992 · 159 citations · Full text

Medicine, Pharmacology, Oxidative Stress +1

Induction of Drug Metabolism Enzymes and MDR1 Using a Novel Human Hepatocyte Cell Line

Jessica B. Mills, Kelly Rose, Nalini Sadagopan et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 140 citations

Genetic analysis of the S-mephenytoin polymorphism in a chinese population*

Sonia M. F. de Morais, Joyce A. Goldstein, Hong‐Guang Xie et al. · Clinical Pharmacology & Therapeutics · 1995 · 134 citations